Abbott Laboratories

Abbott Laboratories discovers, develops, manufactures, and sells healthcare products worldwide. The company operates in four segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. It provides various pharmaceuticals for treating conditions like pancreatic insufficiency and migraines. Abbott also offers diagnostic systems, including laboratory testing and molecular diagnostics. Additionally, the company provides nutritional products, rhythm management devices, diabetes care products, and neuromodulation devices. Founded in 1888, Abbott Laboratories is based in North Chicago, Illinois. The company provides a range of healthcare solutions globally.

Overview

Sector

Medical Devices

Target Price

41.0 USD

Current Price

130.3 USD

Potential

-69%

Strengths

Current Price to Earnings Ratio (16.70) is lower than the sector mean (123.56).
The company has high returns. ROIC (13.85%) is higher than the sector mean (2.97%).
Strong EBITDA Margin of 25.66%.

Weaknesses

With a depreciation Potential of -68.30%, based on our fundamental analysis, it suggests the stock may be overvalued.
Analysts expect revenues to decline in the coming year.

Key Financial Data

Indicator	Value
PER	16.8
EV/EBITDA	21.6
Price/Free Cash Flow'	35.5
ROIC	13.9%
Net Debt/EBITDA	0.6